1. Home
  2. BLBD vs TSHA Comparison

BLBD vs TSHA Comparison

Compare BLBD & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

N/A

Current Price

$49.70

Market Cap

1.7B

ML Signal

N/A

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

N/A

Current Price

$5.08

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLBD
TSHA
Founded
1927
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BLBD
TSHA
Price
$49.70
$5.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$64.60
$10.56
AVG Volume (30 Days)
460.2K
2.5M
Earning Date
02-04-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
22.79
N/A
EPS
3.88
N/A
Revenue
$1,480,099,000.00
$6,310,000.00
Revenue This Year
$4.86
N/A
Revenue Next Year
$3.41
N/A
P/E Ratio
$12.64
N/A
Revenue Growth
9.87
N/A
52 Week Low
$30.04
$1.05
52 Week High
$61.95
$6.02

Technical Indicators

Market Signals
Indicator
BLBD
TSHA
Relative Strength Index (RSI) 51.68 49.78
Support Level $47.43 $4.40
Resistance Level $50.34 $5.17
Average True Range (ATR) 1.41 0.36
MACD 0.25 -0.06
Stochastic Oscillator 81.82 50.77

Price Performance

Historical Comparison
BLBD
TSHA

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: